Sunday, November 22, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Health

DR. Reddy’s acquires Glenmark brands

Fiinews by Fiinews
November 30, 2020
in Health, Investment
Reading Time: 2 mins read
A A
0
Glenmark
0
SHARES
11
VIEWS
LinkedinShare on Twitter

The brands add to core markets

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as Dr. Reddy’s) has entered into a definitive agreement with Glenmark Pharmaceuticals Ltd to acquire, subject to completion of certain precedent actions and closing activities, brands Momat Rino.

These Momat Rino are (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along-with rights to the trademarks, dossiers and patents for the territories mentioned.

The acquired brands represent two types of products, (a) mometasone mono-product and (b) combination of mometasone with azelastine, and are indicated for the treatment of Seasonal and Perennial Allergic Rhinitis.

“The new brands are a great addition to our product portfolio in Russia, Ukraine, Kazakhstan and Uzbekistan which are important core markets for us,” M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets) of Dr. Reddy’s said on 28 Nov 2020.

Momat Rino, the largest brand acquired, has recently received OTC registration in Russia and this will enable accelerated access of this product to patients.

“The acquired products will further add to Dr. Reddy’s strong presence in the anti-allergy segment in these countries, and will also enable us to offer a more comprehensive solution to patients in this area,” he said. #health #investment /fiinews.com

Tags: DR. Reddy
ShareTweetShare

Related Posts

PIB, IACC
Investment

Invest: US capital and Indian talent can transform economy

by Fiinews
November 21, 2026
0
18

Minister says India-US are two vibrant democracies that shape global narrative Highlighting the significance of the India-US economic partnership, Commerce...

PM at FICCI AGM
Investment

Invest: PM applauds rating agencies take on economy

by Fiinews
November 21, 2026
0
25

FICCI urged to look beyond its century of achievements and plan for next 20 years Prime Minister Narendra Modi has...

BRACCO

Invest: Italian companies keen on India

November 20, 2026
23
Perma Pipe

Invest: Perma-Pipe acquires 51% of Welspun unit

November 20, 2026
48
Gentari Logo

Invest: KKR takes minority stake in Gentari

November 20, 2026
27
HZL and Vedanta combined logo

Invest: HZL to double production to 2 mtpa

November 19, 2026
22
SBI YONO

Recent News

  • Tender: PM inaugurates projects in Vaishali
  • Manufacture: BRIC aims for $1trn bioeconomy by 2047
  • Export: Ministers review 6th round of CEPA in Delhi
  • Market: Greaves expands global marine business
  • Market: Polycab strengthens presence in US

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.